With NCI designation, UF Health Cancer Center accelerates research impact
On the anniversary of achieving NCI designation, a look at 10 key achievements over the past year.
On the anniversary of achieving NCI designation, a look at 10 key achievements over the past year.
Recipients are recognized for efforts that benefit ASCO, the speciality of oncology and the patients they serve.
The five-year award aims to encourage the development of stable research career opportunities for exceptional clinician scientists.
Thomas George, M.D., deputy director of the UF Health Cancer Center, discussed NCI designation at the breakfast on Sept. 13.
The committee guides and implements activities to disseminate best practices across AACI cancer center clinical trials offices.
Thomas George, M.D., FACP, becomes deputy director and Paul Crispen, M.D., becomes associate director for clinical research.
Thomas George, M.D., FACP, was a coauthor on the study presented at the ASCO Annual Meeting. UF Health participated in the multicenter study.
Thomas George, M.D., FACP, and Merry Jennifer Markham, M.D., FACP, FASCO, were honored for exemplifying cancer care advocacy in 2022.
Thomas George, M.D., FACP, discussed findings from the phase 2 NRG-GI002 trial in an interview with OncLive at the ASCO GI Symposium.
Universal genetic testing at UF Health identified a relatively large population of older patients with sporadic colorectal cancer who were eligible for immunotherapy.